[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor]

G Ital Cardiol (Rome). 2024 Oct;25(10):747-751. doi: 10.1714/4336.43217.
[Article in Italian]

Abstract

The presence of metastatic cancer represents a high-risk condition for the treatment of heart disease requiring surgical or percutaneous procedures. We present the case of a 58-year-old man with pulmonary adenocarcinoma and renal metastases surviving more than 3 years after chemotherapy and immunotherapy suffering dyspnea and chest pain on minimal exertion due to 99% anterior coronary artery stenosis associated with severe aortic stenosis of a bicuspid valve. We treated the cardiac lesions in two steps by coronary angioplasty with drug-eluting stent implantation followed by percutaneous prosthetic aortic valve replacement. The procedures were successful with resolution of the symptoms and recovery of the usual ECOG-PS 0-1 functional capacity which persists 24 months after cardiac procedures. This case demonstrates that the multidisciplinary collaboration between oncologists and cardiologists with a personalized patient-centered approach allows to treat complex clinical situations successfully in the emerging category of patients surviving with metastatic cancer.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / therapy
  • Angioplasty, Balloon, Coronary / methods
  • Aortic Valve Stenosis* / surgery
  • Cancer Survivors
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Coronary Stenosis / therapy
  • Drug-Eluting Stents*
  • Heart Valve Prosthesis Implantation / methods
  • Humans
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / secondary
  • Lung Neoplasms* / therapy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Treatment Outcome